Cyclerion Therapeutics (CYCN) Total Debt (2019 - 2021)

Cyclerion Therapeutics has reported Total Debt for 3 years, with the latest figure at $3.5 million in Q3 2021.

• On a quarterly basis, Total Debt fell 12.36% year-over-year to $3.5 million in Q3 2021; TTM through Sep 2021 was $3.5 million, a 12.36% decrease from a year earlier, with the FY2020 full-year figure at $3.8 million, up 4585.19% from the prior year.
• Total Debt was $3.5 million for Q3 2021 at Cyclerion Therapeutics, roughly flat from $3.5 million in the prior quarter.
• The five-year high for Total Debt was $4.0 million in Q3 2020, with the low at $59000.0 in Q1 2020.
• Average Total Debt over 3 years is $2.4 million, with a median of $3.5 million recorded in 2021.
• The largest YoY upside for Total Debt was 5847.46% in 2021 against a maximum downside of 12.36% in 2021.
• Over 3 years, Total Debt stood at $81000.0 in 2019, then surged by 4585.19% to $3.8 million in 2020, then slipped by 7.54% to $3.5 million in 2021.
• The last three Total Debt figures came in at $3.5 million (Q3 2021), $3.5 million (Q2 2021), and $3.5 million (Q1 2021), per Business Quant data.